| Literature DB >> 9855533 |
W U Mirza1, I W Rak, V M Thadani, J J Cereghino, W R Garnett, L M Brown, Y Zhang, G W Belendiuk.
Abstract
We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9855533 DOI： 10.1212/wnl.51.6.1727
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910